Your browser is no longer supported. Please, upgrade your browser.
TWST Twist Bioscience Corporation daily Stock Chart
Twist Bioscience Corporation
Index- P/E- EPS (ttm)-3.22 Insider Own21.10% Shs Outstand27.37M Perf Week11.79%
Market Cap627.87M Forward P/E- EPS next Y-2.66 Insider Trans- Shs Float17.80M Perf Month-2.59%
Income-76.90M PEG- EPS next Q-0.97 Inst Own32.40% Short Float2.23% Perf Quarter-5.91%
Sales32.60M P/S19.26 EPS this Y-20.10% Inst Trans63.62% Short Ratio2.66 Perf Half Y-
Book/sh7.22 P/B3.18 EPS next Y34.00% ROA- Target Price28.50 Perf Year-
Cash/sh4.76 P/C4.82 EPS next 5Y- ROE- 52W Range12.38 - 34.46 Perf YTD-0.65%
Dividend- P/FCF- EPS past 5Y- ROI37.00% 52W High-33.43% Beta-
Dividend %- Quick Ratio7.40 Sales past 5Y- Gross Margin-12.10% 52W Low85.30% ATR1.69
Employees289 Current Ratio7.70 Sales Q/Q167.40% Oper. Margin- RSI (14)54.54 Volatility7.74% 7.82%
OptionableNo Debt/Eq0.07 EPS Q/Q-85.40% Profit Margin- Rel Volume0.45 Prev Close22.41
ShortableYes LT Debt/Eq0.05 EarningsFeb 07 AMC Payout- Avg Volume148.98K Price22.94
Recom2.00 SMA202.87% SMA500.24% SMA2001.45% Volume67,738 Change2.37%
Nov-26-18Initiated JP Morgan Neutral $27
Feb-07-19 06:03PM  Twist Bioscience: Fiscal 1Q Earnings Snapshot Associated Press
04:05PM  Twist Bioscience Reports First Quarter Fiscal 2019 Financial Results and Highlights Commercial and Operational Progress Business Wire
04:04PM  Twist Bioscience Announces Appointment of Martin Kunz as Senior Vice President, Operations Business Wire
Jan-30-19 08:00AM  Twist Bioscience Chief Technology Officer Presented at Praesens Foundation Future Health Threats Initiative 2019 Business Wire
Jan-29-19 09:38AM  What's next for this slow-moving Peninsula biotech IPO? American City Business Journals
Jan-28-19 08:00AM  Twist Bioscience to Report Fiscal 2019 First Quarter Financial Results on Thursday, February 7, 2019 Business Wire
Jan-23-19 08:00AM  Twist Bioscience Receives ISO 13485:2016 and 9001:2015 Certifications of its Quality Management Systems for NGS Target Enrichment Panels Business Wire
Jan-11-19 02:05PM  8 of the 10 biggest Q4 startup exits in Bay Area came from IPOs in October American City Business Journals -5.12%
Jan-09-19 09:09AM  Government shutdown may mean an IPO-less January American City Business Journals
Jan-07-19 08:00AM  Twist Bioscience Enhances Genes Product Offering with Longer Genes and Offers Access to Its Application Programming Interface Business Wire
Jan-02-19 08:00AM  Twist Bioscience to Present at the 37th Annual J.P. Morgan Healthcare Conference Business Wire +5.93%
Dec-20-18 09:48PM  Twist Bioscience Corp (TWST) Files 10-K for the Fiscal Year Ended on September 30, 2018 -11.21%
Dec-19-18 04:05PM  Twist Bioscience Reports Fiscal 2018 Fourth Quarter and Full Year Financial Results and Highlights Commercial and Operational Progress Business Wire
Dec-10-18 10:58AM  Here's Why Twist Bioscience Stock Soared 89% in November Motley Fool -15.94%
Dec-05-18 08:00AM  Twist Bioscience to Report Fiscal 2018 Fourth Quarter and Full Year Financial Results on Wednesday, December 19, 2018 Business Wire
Nov-27-18 08:00AM  Twist Bioscience to Present at the Evercore ISI HealthCONx Conference Business Wire -9.29%
Nov-26-18 02:03PM  Here's how much better insiders have profited from this year's IPO boom American City Business Journals
08:00AM  Twist Bioscience Appoints Experienced Technology Executive Jan Johannessen to Board of Directors Business Wire
Oct-31-18 02:45PM  Twist Bioscience Corporation Announces Pricing of Initial Public Offering Business Wire
Oct-28-18 10:53AM  IPO Outlook For The Week: Banks And Biotechs Benzinga
Twist Bioscience Corporation, a synthetic biology company, manufactures and sells synthetic DNA-based products. The company's DNA synthesis platform enables the manufacturing of synthetic DNA by writing DNA on a silicon chip. It offers synthetic DNA-based products, including synthetic genes, tools for sample preparation, antibody libraries for drug discovery and development, and DNA as a digital data storage medium. The company was founded in 2013 and is headquartered in San Francisco, California.